Class information for:
Level 1: NK 104//PITAVASTATIN//CAS 147526 32 7

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
18625 477 37.6 85%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
408 16067 STATINS//EZETIMIBE//SIMVASTATIN

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 NK 104 Author keyword 31 92% 3% 12
2 PITAVASTATIN Author keyword 29 37% 13% 63
3 CAS 147526 32 7 Author keyword 4 56% 1% 5
4 MONOCALCIUM BIS3R 5S 6E 7 2 CYCLOPROPYL 4 4 FLUOROPHENYL 3 QUINOLYL 3 5 DIHYDROXY 6 HEPTENOATE Author keyword 3 100% 1% 3
5 PITAVASTATIN CALCIUM Author keyword 3 45% 1% 5
6 ARTERIOSCLEROT METAB MED Address 1 100% 0% 2
7 NUCLEO INVEST ARTERIAL Address 1 100% 0% 2
8 PITAVASTATIN LACTONE Author keyword 1 100% 0% 2
9 SHIRAOKA STN BIOL SCI Address 1 20% 1% 6
10 DIABETOGENICITY Author keyword 1 40% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 NK 104 31 92% 3% 12 Search NK+104 Search NK+104
2 PITAVASTATIN 29 37% 13% 63 Search PITAVASTATIN Search PITAVASTATIN
3 CAS 147526 32 7 4 56% 1% 5 Search CAS+147526+32+7 Search CAS+147526+32+7
4 MONOCALCIUM BIS3R 5S 6E 7 2 CYCLOPROPYL 4 4 FLUOROPHENYL 3 QUINOLYL 3 5 DIHYDROXY 6 HEPTENOATE 3 100% 1% 3 Search MONOCALCIUM+BIS3R+5S+6E+7+2+CYCLOPROPYL+4+4+FLUOROPHENYL+3+QUINOLYL+3+5+DIHYDROXY+6+HEPTENOATE Search MONOCALCIUM+BIS3R+5S+6E+7+2+CYCLOPROPYL+4+4+FLUOROPHENYL+3+QUINOLYL+3+5+DIHYDROXY+6+HEPTENOATE
5 PITAVASTATIN CALCIUM 3 45% 1% 5 Search PITAVASTATIN+CALCIUM Search PITAVASTATIN+CALCIUM
6 PITAVASTATIN LACTONE 1 100% 0% 2 Search PITAVASTATIN+LACTONE Search PITAVASTATIN+LACTONE
7 DIABETOGENICITY 1 40% 0% 2 Search DIABETOGENICITY Search DIABETOGENICITY
8 NEW ONSET DIABETES MELLITUS 1 14% 1% 5 Search NEW+ONSET+DIABETES+MELLITUS Search NEW+ONSET+DIABETES+MELLITUS
9 2 H GLUCOSE 1 50% 0% 1 Search 2+H+GLUCOSE Search 2+H+GLUCOSE
10 3 HYDROXY 3 METHYLGLUTARYL HMG COA REDUCTASE INHIBITOR 1 50% 0% 1 Search 3+HYDROXY+3+METHYLGLUTARYL+HMG+COA+REDUCTASE+INHIBITOR Search 3+HYDROXY+3+METHYLGLUTARYL+HMG+COA+REDUCTASE+INHIBITOR

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 COMBINED DYSLIPIDEMIA 13 67% 3% 12
2 NK 104 10 52% 3% 14
3 ATHEROSCLEROSIS PREVENTION CHIBA 6 71% 1% 5
4 LIVALO EFFECTIVENESS 6 100% 1% 4
5 SAFETY LIVES 6 100% 1% 4
6 ACTIVATED RECEPTOR LIGANDS 3 100% 1% 3
7 RETROSPECTIVE LONGITUDINAL COHORT 3 100% 1% 3
8 JAPAN ASSESSMENT 3 50% 1% 4
9 SUB ANALYSIS 3 42% 1% 5
10 AFFECT INSULIN SENSITIVITY 1 50% 0% 2

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Statin treatment and new-onset diabetes: A review of proposed mechanisms 2014 18 88 36%
Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis 2011 326 30 13%
Is statin-induced diabetes clinically relevant? A comprehensive review of the literature 2014 6 45 49%
Differential metabolic effects of distinct statins 2011 47 71 49%
The clinical impact of pitavastatin: comparative studies with other statins on LDL-C and HDL-C 2012 7 12 83%
Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2 2011 40 49 47%
Statin therapy and related risk of new-onset type 2 diabetes mellitus 2014 5 39 41%
Pitavastatin in cardiometabolic disease: therapeutic profile 2013 8 55 45%
Are statins diabetogenic? 2011 35 42 38%
How to balance cardiorenometabolic benefits and risks of statins 2014 4 54 37%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 ARTERIOSCLEROT METAB MED 1 100% 0.4% 2
2 NUCLEO INVEST ARTERIAL 1 100% 0.4% 2
3 SHIRAOKA STN BIOL SCI 1 20% 1.3% 6
4 UNIV HOSP ST JOAN 1 40% 0.4% 2
5 BHF GLASGOW CARDIOVASCULAR 1 50% 0.2% 1
6 CHINESE MINIST EDUC CHINESE MINIST PUBL HLTH 1 50% 0.2% 1
7 CLIN EPIDEMIOL BIOSTATPERELMAN MED 1 50% 0.2% 1
8 COMPLIMENTARY ALTERNAT MED 1 50% 0.2% 1
9 COPENHAGEN UNIV HOSP HLTH MED SCI 1 50% 0.2% 1
10 ENDOCRINOL METABLIPIDS LIM 10 1 50% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000175118 STATINS//LOW DENSITY LIPOPROTEIN CHOLESTEROL//ATORVASTATIN
2 0.0000146238 FLUVASTATIN//PLEIOTROPIC EFFECTS//HMG COA REDUCTASE INHIBITOR
3 0.0000119528 EZETIMIBE//CHOLESTEROL ABSORPTION INHIBITOR//COLESEVELAM
4 0.0000115623 STATIN MYOPATHY//STATIN INTOLERANCE//MYALGIA
5 0.0000095154 OATP1B1//SLCO1B1//OATP
6 0.0000086206 TORCETRAPIB//HIGH DENSITY LIPOPROTEIN//ANACETRAPIB
7 0.0000075427 TG HDL C RATIO//TRIGLYCERIDE TO HDL CHOLESTEROL RATIO//DEOB
8 0.0000073881 FENOFIBRIC ACID//FENOFIBRATE//FIBRATES
9 0.0000073408 ABCA1//TANGIER DISEASE//ATP BINDING CASSETTE TRANSPORTER A1
10 0.0000071412 PRAVASTATIN//HMG COA REDUCTASE INHIBITOR//COMPACTIN